Source: The Pharma Letter

Igenica: Pierre Fabre sets sights on bigger I-O business

Privately-held Pierre Fabre Pharmaceuticals is buying immuno-oncological candidates from Igenica Biotherapeutics,...

Read full article »
Igenica's Competitors | Igenica's News | Igenica's Financials
Stay up-to-date with the latest news on Igenica
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Robert Schreiber's photo - Co-Founder of Igenica

Co-Founder

Robert Schreiber

CEO Approval Rating

78/100

Read more
Stay up-to-date with the latest news on Igenica